HomepageEarnings Events Newsdesk 14 hours ago Johnson & Johnson (JNJ) Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE) Johnson & Johnson (NYSE: JNJ) FY 2026 Other Release Lumentum Holdings Inc (LITE) Sec Form 8K » « FactSet Research Systems Inc (FDS) FactSet Integrates Advanced AI Financial Crime Risk Management Tools into Workstation for Corporate Banks Newsdesk: